Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
µé¹®¾ÏÀε¥ ¸Å¿ì ½ÉÇß°í ¿ø°ÝÀüÀÌ°¡ ÀÖ¾ú½À´Ï´Ù. ½Äµµ·Î ÀüÀÌµÈ Á¡ÀÌ ´õ¿í ƯÀÌÇß½À´Ï´Ù. PET ¼Ò°ß¿¡ ÀÚ¼¼È÷ ±â¼úµÇ¾î ÀÖ¾î¼ ±×´ë·Î ¿Å±é´Ï´Ù. ³Ê¹« ÀÚ¼¼È÷ Æǵ¶ÇØÁּż ±ô¦ ³î¶ú½À´Ï´Ù.
known stomach cancer
initial w/u
Glucose : 97 mg/dl
346 MBqÀÇ F-18 FDG¸¦ Á¤¸ÆÁÖ»çÇÏ°í basal skullºÎÅÍ mid-thigh ºÎÀ§±îÁö CT·Î º¸Á¤ÇÏ¿© PET¿µ»óÀ» ¾ò¾úÀ½.
Lower thoracic esophagus¿¡¼ºÎÅÍ stomach cardia, body±îÁö p-SUV = 13.0ÀÎ FDG ¼·ÃëÁõ°¡°¡ º¸À̸ç malignancyÀÏ °ÍÀ¸·Î »ý°¢ÇÔ. Left IV cervical lymph node(p-suv =7.0), left supraclavicular lymph node(p-SUV = 5.9), left highest mediastinal lymph node(p-SUV = 4.0), left upper paratracheal lymph node(p-SUV = 4.5), left lower paratracheal lymph node(p-SUV = 3.3), left lower paraesophageal lymph node(p-SUV = 3.6)¿¡ FDG ¼·ÃëÁõ°¡°¡ º¸À̸ç metastatic lymphadenopathyÀÏ °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î »ý°¢ÇÔ.
Left gastric lymph node(p-SUV = 6.4), common hepatic artery lymph node(p-SUV = 4.6), celiac lymph node(p-SUV = 4.3), aortocaval lymph node(p-SUV = 2.8), left paraaortic lymph node(p-SUV = 4.2), retrocaval lymph node(p-SUV = 2.8), splenic hilar lymph node(p-SUV = 4.5)¿¡ FDG ¼·ÃëÁõ°¡°¡ º¸À̸ç malignant lymphadenopathyÀÏ °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î »ý°¢ÇÔ.
Left acromioclavicular junction, right shoulder joint¿¡¼ º¸ÀÌ´Â mild FDG ¼·ÃëÁõ°¡´Â benign joint problem¿¡ ÀÇÇÑ °ÍÀ¸·Î »ý°¢ÇÔ. Right level II cervical lymph node¿¡ p-SUV = 3.6ÀÎ FDG ¼·ÃëÁõ°¡°¡ º¸À̸ç benign reactive changeÀÏ °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î »ý°¢ÇÔ.
Right lung upper lobe¿Í right lung middle lobe¿¡ FDG ¼·Ãë¾ø´Â pulmonary noduleÀÌ ÀÖÀ¸¸ç benign lesionÀÏ °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î »ý°¢ÇÔ. ÀÌ»óÀ¸·Î º¸¾Æ N3M1 stageÀÎ °ÍÀ¸·Î »ý°¢ÇÔ.
¢Ã °á·Ð ¹× Áø´Ü
1. Increased FDG uptake in the lower thoracic esophagus to stomach cardia and body, c/w malignancy.
2. Increased FDG uptake in the left level IV cervical lymph node, left supraclavicular lymph node, left highest mediastinal lymph node, left upper paratracheal lymph node, left lower paratracheal lymph node and left lower paraesophageal lymph node, metastatic lymphadenopathy more likely.
3. Increased FDG uptake in the left gastric lymph node, common hepatic artery lymph node, celiac lymph node, aortocaval lymph node, left paraaortic lymph node, retrocaval lymph node and splenic hilar lymph node, metastatic lymphadenopathy more likely.
4. Mild uptake in the left acromioclavicular junction and right shoulder joint, benign joint problem more likely.
5. Mild FDG uptake in the right level II cervical lymph node, benign reactive change more likely.
6. Pulmonary nodules in the right lung upper lobe and right lung middle lobe without FDG uptake, benign lesion more likely.